Patents by Inventor John T. Butterfield

John T. Butterfield has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11971412
    Abstract: Complexes containing a labeled polypeptide and an antibody, and the use of such complexes as research, diagnostic, and clinical tools, are described herein.
    Type: Grant
    Filed: November 8, 2022
    Date of Patent: April 30, 2024
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Wendy K. Nevala, Svetomir N. Markovic, John T. Butterfield, Daniel J. Knauer
  • Publication number: 20230273212
    Abstract: Complexes containing a labeled polypeptide and an antibody, and the use of such complexes as research, diagnostic, and clinical tools, are described herein.
    Type: Application
    Filed: November 8, 2022
    Publication date: August 31, 2023
    Inventors: Wendy K. Nevala, Svetomir N. Markovic, John T. Butterfield, Daniel J. Knauer
  • Patent number: 11531030
    Abstract: Complexes containing a labeled polypeptide and an antibody, and the use of such complexes as research, diagnostic, and clinical tools, are described herein.
    Type: Grant
    Filed: April 20, 2018
    Date of Patent: December 20, 2022
    Assignee: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
    Inventors: Wendy K. Nevala, Svetomir N. Markovic, John T. Butterfield, Daniel J. Knauer
  • Publication number: 20210132068
    Abstract: Complexes containing a labeled polypeptide and an antibody, and the use of such complexes as research, diagnostic, and clinical tools, are described herein.
    Type: Application
    Filed: April 20, 2018
    Publication date: May 6, 2021
    Inventors: Wendy K. Nevala, Svetomir N. Markovic, John T. Butterfield, Daniel J. Knauer
  • Publication number: 20210023233
    Abstract: Materials and methods for diagnosing and treating clinical conditions such as cancer using polypeptide complexes that include (a) a polypeptide component, (b) a therapeutic agent or a label, and (c) an antibody, are provided herein. Specifically, the polypeptide complex comprising: (a) a specified polypeptide component, (b) one or more cisplatin molecules or the polypeptide is labeled with 99Tcm, and (c) a monoclonal antibody that specifically binds to a tumor antigen, for treating or diagnosing cancer, respectively.
    Type: Application
    Filed: February 6, 2019
    Publication date: January 28, 2021
    Applicant: Mayo Foundation for Medical Education and Research
    Inventors: Wendy K. Nevala, Svetomir N. Markovic, John T. Butterfield, Daniel J. Knauer